About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Malaria Vaccine may be too Costly for Success

by Bidita Debnath on October 23, 2013 at 10:52 PM
Font : A-A+

 New Malaria Vaccine may be too Costly for Success

A promising new malaria vaccine being tested by GlaxoSmithKline is a step in the right direction, but much more economical methods are needed.

Laura Harrington, professor of entomology at Cornell University and an expert in global health and epidemiology, said that despite a resurgence in the global effort to fight malaria, the war on this deadly mosquito borne infection has overwhelmed scientists, policy makers, and government officials alike.

Advertisement

She said that major challenges, like behavioral and biochemical resistance by malaria vectors, and the flood of fake antimalarial drugs in the marketplace have all taken their toll.

Harrington asserted that the world's first successful malaria vaccine is almost within reach. A malaria vaccine has long been viewed as the 'holy grail of tropical medicine.'
Advertisement

Although the GlaxoSmithKline RTS vaccine doesn't protect all immunized children - only a 46 percent reduction in malaria incidence for children 5 to 17 months, and 27 percent for those 6 to 12 weeks of age - it is better than no vaccine, and it could be used together with other strategies like vector control to reduce malaria illness and mortality.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Malaria-water Malaria Mosquito Diseases Vaccination for Children Fever Top 10 Vaccine Myths Debunked Malaria - Protection Strategies 

Recommended Reading
India, Africa Don't Get Hopes Up on Malaria Vaccine
Countries like India and Africa - hotbeds for malaria - await the world's first vaccine against the ...
Potential Malaria Vaccine Triggers Optimism and Caution Among Experts in Africa
The reaction among experts in Africa, the continent worst-hit by malaria, was optimism but also ......
GSK Hopes for Approval from EMA for Prototype Malaria Vaccine
British drug maker GlaxoSmithKline (GSK) expressed optimism that it will be approved by European ......
Malaria Vaccine Offers 100 Percent Protection by Mimicking the Effects of a Mosquito Bite
A new vaccine for malaria, that supposedly imitates the effects of a mosquito bite, is offering a .....
Fever
Fever or Pyrexia is an elevation in normal body temperature. Causes of fever include infections, inj...
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is ch...
Malaria - Protection Strategies
Malaria is a dangerous disease with lethal consequences that requires protective measures for preven...
Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of mosqu...
Top 10 Vaccine Myths Debunked
Childhood vaccination has saved many lives, yet lots more has to be done to increase awareness and e...
Vaccination for Children
Vaccines are biological products that impart immunity to the recipient. Vaccines may be live attenua...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use